| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3268485 | HPB | 2016 | 11 Pages |
Abstract
Non-invasive IPMN with high-grade dysplasia should not be considered a malignant entity. Compared to patients with IPMN with low/intermediate-grade dysplasia, those with high-grade dysplasia have an increased risk of subsequent development of PDAC in the remnant pancreas.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Neda Rezaee, Carlotta Barbon, Ahmed Zaki, Jin He, Bulent Salman, Ralph H. Hruban, John L. Cameron, Joseph M. Herman, Nita Ahuja, Anne Marie Lennon, Matthew J. Weiss, Laura D. Wood, Christopher L. Wolfgang,